{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:29:42Z","timestamp":1792654182304,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,21]],"date-time":"2020-05-21T00:00:00Z","timestamp":1590019200000},"content-version":"vor","delay-in-days":386,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012728","name":"Frederick National Laboratory for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HHSN261200800001E"],"award-info":[{"award-number":["HHSN261200800001E"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunity"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.immuni.2019.03.010","type":"journal-article","created":{"date-parts":[[2019,4,9]],"date-time":"2019-04-09T12:50:40Z","timestamp":1554814240000},"page":"1305-1316.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":177,"title":["Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells"],"prefix":"10.1016","volume":"50","author":[{"given":"Wei","family":"Bu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Gordon","family":"Joyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalton V.","family":"Banh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeshan","family":"Tariq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moh Lan","family":"Yap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tsujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca A.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaroslav","family":"Tsybovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep R.","family":"Narpala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian B.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Rossmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Yasutomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary J.","family":"Nabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Kanekiyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey I.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.immuni.2019.03.010_bib1","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.8248784","article-title":"The influence of antigen organization on B cell responsiveness","volume":"262","author":"Bachmann","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.immuni.2019.03.010_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0378-1119(95)00149-Z","article-title":"Selection of recombinant vaccinia viruses on the basis of plaque formation","volume":"158","author":"Blasco","year":"1995","journal-title":"Gene"},{"key":"10.1016\/j.immuni.2019.03.010_bib3","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkn316","article-title":"IMGT\/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis","volume":"36","author":"Brochet","year":"2008","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.immuni.2019.03.010_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/s41564-017-0081-7","article-title":"Ephrin receptor A2 is a functional entry receptor for Epstein-Barr virus","volume":"3","author":"Chen","year":"2018","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.immuni.2019.03.010_bib5","doi-asserted-by":"crossref","first-page":"13214","DOI":"10.1128\/JVI.05580-11","article-title":"Fusion of Epstein-Barr virus with epithelial cells can be triggered by \u03b1v\u03b25 in addition to \u03b1v\u03b26 and \u03b1v\u03b28, and integrin binding triggers a conformational change in glycoproteins gHgL","volume":"85","author":"Chesnokova","year":"2011","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib6","doi-asserted-by":"crossref","first-page":"20464","DOI":"10.1073\/pnas.0907508106","article-title":"Fusion of epithelial cells by Epstein-Barr virus proteins is triggered by binding of viral glycoproteins gHgL to integrins alphavbeta6 or alphavbeta8","volume":"106","author":"Chesnokova","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib7","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.1158\/1078-0432.CCR-15-2299","article-title":"High levels of antibody that neutralize b-cell infection of Epstein-barr virus and that bind ebv gp350 are associated with a lower risk of nasopharyngeal carcinoma","volume":"22","author":"Coghill","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.immuni.2019.03.010_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.immuni.2019.03.010_bib9","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1038\/cti.2014.27","article-title":"Epstein-barr virus vaccines","volume":"4","author":"Cohen","year":"2015","journal-title":"Clin. Transl. Immunology"},{"key":"10.1016\/j.immuni.2019.03.010_bib10","doi-asserted-by":"crossref","first-page":"107fs7","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus:\u00a0an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2019.03.010_bib11","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"Delecluse","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib12","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1073\/pnas.79.3.884","article-title":"Specific cellular stimulation in the primary immune response: experimental test of a quantized model","volume":"79","author":"Dintzis","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib13","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nbt1087","article-title":"Stable antibody expression at therapeutic levels using the 2A peptide","volume":"23","author":"Fang","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.immuni.2019.03.010_bib14","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","article-title":"Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2","volume":"81","author":"Fingeroth","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.str.2011.12.014","article-title":"Outcome of the first electron microscopy validation task force meeting","volume":"20","author":"Henderson","year":"2012","journal-title":"In Structure"},{"key":"10.1016\/j.immuni.2019.03.010_bib16","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1073\/pnas.77.5.2979","article-title":"Monoclonal antibody against a 250,000-dalton glycoprotein of Epstein-Barr virus identifies a membrane antigen and a neutralizing antigen","volume":"77","author":"Hoffman","year":"1980","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib17","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.010_bib18","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.cell.2015.07.043","article-title":"Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site","volume":"162","author":"Kanekiyo","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.immuni.2019.03.010_bib19","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.1128\/JVI.00572-06","article-title":"Soluble Epstein-Barr virus glycoproteins gH, gL, and gp42 form a 1:1:1 stable complex that acts like soluble gp42 in B-cell fusion but not in epithelial cell fusion","volume":"80","author":"Kirschner","year":"2006","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib20","doi-asserted-by":"crossref","first-page":"9216","DOI":"10.1128\/JVI.00575-07","article-title":"Binding-site interactions between Epstein-Barr virus fusion proteins gp42 and gH\/gL reveal a peptide that inhibits both epithelial and B-cell membrane fusion","volume":"81","author":"Kirschner","year":"2007","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib21","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/356347a0","article-title":"Epstein-Barr virus infection and replication in a human\u00a0epithelial cell system","volume":"356","author":"Li","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.immuni.2019.03.010_bib22","doi-asserted-by":"crossref","first-page":"3987","DOI":"10.1128\/jvi.69.7.3987-3994.1995","article-title":"The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells","volume":"69","author":"Li","year":"1995","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib23","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1128\/jvi.71.6.4657-4662.1997","article-title":"Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes","volume":"71","author":"Li","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib24","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.0404535101","article-title":"Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins","volume":"101","author":"McShane","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib25","doi-asserted-by":"crossref","first-page":"6324","DOI":"10.1128\/JVI.74.14.6324-6332.2000","article-title":"Epstein-Barr virus gH is essential for penetration of B cells but also\u00a0plays a role in attachment of virus to epithelial cells","volume":"74","author":"Molesworth","year":"2000","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib26","doi-asserted-by":"crossref","first-page":"309ra162","DOI":"10.1126\/scitranslmed.aac4241","article-title":"Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera","volume":"7","author":"Ngwuta","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.immuni.2019.03.010_bib27","doi-asserted-by":"crossref","first-page":"12408","DOI":"10.1128\/JVI.79.19.12408-12415.2005","article-title":"The amino terminus of Epstein-Barr virus glycoprotein gH is important for fusion with epithelial and B cells","volume":"79","author":"Omerovi\u0107","year":"2005","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib28","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.virol.2009.06.013","article-title":"Human antibody titers to Epstein-Barr Virus (EBV) gp350 correlate with neutralization of infectivity better than antibody titers to EBV gp42 using a rapid flow cytometry-based EBV neutralization assay","volume":"391","author":"Sashihara","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2019.03.010_bib29","doi-asserted-by":"crossref","first-page":"13557","DOI":"10.1038\/ncomms13557","article-title":"Structural basis for Epstein-Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins","volume":"7","author":"Sathiyamoorthy","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.immuni.2019.03.010_bib30","doi-asserted-by":"crossref","first-page":"E8703","DOI":"10.1073\/pnas.1704661114","article-title":"Inhibition of EBV-mediated membrane fusion by anti-gHgL antibodies","volume":"114","author":"Sathiyamoorthy","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib31","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1073\/pnas.0510512103","article-title":"Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells","volume":"103","author":"Shannon-Lowe","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib32","doi-asserted-by":"crossref","first-page":"5946","DOI":"10.1128\/JVI.78.11.5946-5956.2004","article-title":"Mutational analyses of Epstein-Barr virus glycoprotein 42 reveal functional domains not involved in receptor binding but required for membrane fusion","volume":"78","author":"Silva","year":"2004","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.immuni.2018.03.026","article-title":"An Antibody Targeting the Fusion Machinery Neutralizes Dual-Tropic Infection and Defines a Site of Vulnerability on Epstein-Barr Virus","volume":"48","author":"Snijder","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.immuni.2019.03.010_bib34","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/523813","article-title":"Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double-blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein-Barr virus vaccine in healthy young adults","volume":"196","author":"Sokal","year":"2007","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.immuni.2019.03.010_bib35","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1099\/vir.0.007237-0","article-title":"Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells","volume":"90","author":"Sorem","year":"2009","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib36","doi-asserted-by":"crossref","first-page":"5557","DOI":"10.1128\/jvi.70.8.5557-5563.1996","article-title":"The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation","volume":"70","author":"Spriggs","year":"1996","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib37","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/jvi.43.2.730-736.1982","article-title":"Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in\u00a0vivo","volume":"43","author":"Thorley-Lawson","year":"1982","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib38","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jim.2007.09.017","article-title":"Efficient generation of monoclonal antibodies from single\u00a0human B cells by single cell RT-PCR and expression vector cloning","volume":"329","author":"Tiller","year":"2008","journal-title":"J.\u00a0Immunol. Methods"},{"key":"10.1016\/j.immuni.2019.03.010_bib39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nm830","article-title":"Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells","volume":"9","author":"Tugizov","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.immuni.2019.03.010_bib40","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.1128\/JVI.72.7.5552-5558.1998","article-title":"Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells","volume":"72","author":"Wang","year":"1998","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib41","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1128\/JVI.03422-13","article-title":"Flow cytometry reveals that H5N1 vaccination elicits cross-reactive stem-directed antibodies from multiple Ig heavy-chain lineages","volume":"88","author":"Whittle","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib42","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.virol.2007.01.025","article-title":"Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion","volume":"363","author":"Wu","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.immuni.2019.03.010_bib43","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1073\/pnas.1713166114","article-title":"Structural studies of Chikungunya virus maturation","volume":"114","author":"Yap","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.immuni.2019.03.010_bib44","doi-asserted-by":"crossref","first-page":"5688","DOI":"10.1128\/jvi.71.7.5688-5691.1997","article-title":"Epstein-Barr virus infection of human gastric carcinoma cells: implication of the existence of a new virus receptor different from CD21","volume":"71","author":"Yoshiyama","year":"1997","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.immuni.2019.03.010_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","article-title":"Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry","volume":"3","author":"Zhang","year":"2018","journal-title":"Nat. Microbiol."}],"container-title":["Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107476131930127X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S107476131930127X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:06:24Z","timestamp":1761033984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S107476131930127X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S107476131930127X"],"URL":"https:\/\/doi.org\/10.1016\/j.immuni.2019.03.010","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735512664.793559449","asserted-by":"object"}]},"ISSN":["1074-7613"],"issn-type":[{"value":"1074-7613","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunization with Components of the Viral Fusion Apparatus Elicits Antibodies That Neutralize Epstein-Barr Virus in B Cells and Epithelial Cells","name":"articletitle","label":"Article Title"},{"value":"Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.immuni.2019.03.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}